News

Check back here regularly to find out what's going on at our company.

Sept 2018: EbD awarded NIH STTR grant to develop a novel AML biologic drug      

Grant title: DEVELOPMENT OF A NOVEL SAFE AND EFFICACIOUS BIOLOGIC DRUG FOR THE TREATMENT OF AML

July 2018: EbD awarded NIH STTR grant to develop a novel L-asparaginase               

Grant title: A NOVEL GLUTAMINASE-FREE MAMMALIAN ASPARAGINASE WITH MINIMIZED IMMUNOGENICITY TO ENABLE EXPANDED USE IN CANCER THERAPY

Feb 2018: UIC Cancer Center publishes writeup on EbD's CEO               

UIC Cancer Center News: UIC Cancer Center publishes writeup on EbD's CEO 

Jan 2018: EbD publishes the advantage of low L-glutaminase L-asparaginase in Cancer Research

Nguyen et al Cancer Research 2018